06622 兆科眼科－Ｂ
按盤價 
3.040 +0.020 (+0.662%) 盈利能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 資產回報率 (%) | -10.002% | -10.184% | -15.429% | -15.739% | -111.158% |
| 股東資金回報率 (%) | -12.024% | -12.030% | -17.515% | -16.818% | -243.470% |
| 資本運用回報率 (%) | -13.005% | -12.302% | -18.477% | -17.142% | -84.636% |
邊際利潤分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 毛利率 (%) | 50.206% | 74.717% | 75.984% | N/A | N/A |
| 未計利息、稅項、折舊及攤銷前利潤率 (%) | -600.303% | -360.128% | -2161.397% | N/A | N/A |
| 稅前邊際利潤率 (%) | -653.600% | -342.584% | -2050.603% | N/A | N/A |
| 純利率 (%) | -653.600% | -342.584% | -2053.536% | N/A | N/A |
變現能力分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 流動比率 (X) | 4.183 X | 5.159 X | 5.334 X | 10.141 X | 24.817 X |
| 速動比率 (X) | 4.139 X | 5.111 X | 5.316 X | 10.141 X | 24.817 X |
財務槓桿分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 總負債 / 總資產比率 (%) | 18.572% | 15.308% | 15.371% | 8.646% | 4.219% |
| 總債項 / 總資產比率 (%) | 15.107% | 10.635% | 9.834% | 5.132% | 1.421% |
| 淨債項 / 總資產比率 (%) | -34.462% | -39.332% | -50.555% | -61.636% | -80.271% |
| 總債項 / 股東資金比率 (%) | 18.552% | 12.557% | 11.621% | 5.618% | 1.484% |
| 長期債項 / 股東資金比率 (%) | 0.597% | 0.845% | 1.067% | 1.180% | 0.836% |
| 淨債項 / 股東資金比率 (%) | -42.322% | -46.441% | -59.737% | -67.469% | -83.807% |
| 淨現金 / (債項) ($) | 6.67億 | 8.82億 | 12.24億 | 15.84億 | 20.91億 |
| 每股淨現金 / (債項) ($) | 1.217 | 1.616 | 2.240 | 2.913 | 3.859 |
| 總債項 / 資本運用比率 (%) | 18.194% | 12.359% | 11.422% | 5.552% | 1.472% |
| 利息盈利率 (X) | N/A | N/A | N/A | N/A | N/A |
營運效率分析
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| 存貨周轉率日數 (日) | 338.509日 | 219.100日 | 497.771日 | N/A | N/A |
| 應收貿易帳周轉率日數 (日) | 88.345日 | 13.397日 | 72.221日 | N/A | N/A |
| 應付貿易帳周轉率日數 (日) | 8.499日 | 6.147日 | 22.698日 | N/A | N/A |
| 備註： | 即時報價更新時間為02/04/2026 17:59 |
| 港股即時基本市場行情由香港交易所提供; 香港交易所指定免費發放即時基本市場行情的網站 | |
| 股東應佔溢利/(虧損) (千) | RMB -208,982 |
| 增長率 | -12.005% |
| 每股盈利/(虧損) | RMB -0.380 |
| 每股帳面資產淨值 (¥) | RMB 2.876 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
